Almost 10 years ago, secondhand smoke was determined to be a Group A carcinogen by the US Environmental Protection Agency (EPA). Since then evidence has grown supporting this classification. The reasoning is based on the content of secondhand smoke (SHS). SHS is a mixture of fine particles and over 50 chemicals that are known or probable cancer causing...
Read More
The New York Times article “Cancers Share Gene Patterns, Studies Affirm” published on May 2, 2013, and several other news outlets, described the work being carried out by The Cancer Genomic Atlas (TCGA). The TCGA, funded by the National Institutes of Health, is a research network consisting of more than 150 researchers at institutions across the...
Read More
A recent study by researchers at Loyola University found that as many as 63% of prostate cancer websites cannot be read or understood by someone who hasn’t completed high school education. Why is this important? Well, one of the study’s references suggests that as many as 90 million adult Americans have literacy skills that test below high school...
Read More
It’s been awhile since my last blog post. I apologize, I’ve been busy. I’ve spent most of my time helping several startups get off the ground, some of which you’ll hear more about very soon. Among these, and the one I’ve spent the bulk of my energy on, is Medivizor. Over the next few weeks and months I’ll be sharing in this blog about the...
Read More
